Loading provider…
Loading provider…
Neurology Physician in Williamsville, NY
NPI: 1184815839Primary Practice Location
KALEIDA HEALTH
100 High St, Buffalo, NY
Primary Employer
University Neurology, Inc.
universityneurologyri.com
HQ Phone
Get MD Marilou's Phone Numberphone_androidMobile
Get MD Marilou's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Cleveland Clinic
fellowship • Vascular Neurology
2006 - 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99223Initial hospital inpatient care, typically 70 minutes per day | 52 | 52 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 52 | 72 |
| 3 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 40 | 40 |
| 4 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 22 | 25 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 21 | 26 |
Lead Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Intervention / Treatment: DEVICE: Reveal LINQ™ Insertable Cardiac Monitor
Lead Sponsor: Temple University
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Medical University of South Carolina, University of Michigan, Neurological Emergencies Treatment Trials Network (NETT), University of Virginia, Augusta University
Intervention / Treatment: OTHER: Glycemic Control
Lead Sponsor: University of Virginia
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Medical University of South Carolina, Neurological Emergencies Treatment Trials Network (NETT)
Intervention / Treatment: DRUG: Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL, DRUG: IV insulin to maintain target glucose concentration of 80-130 mg/dL